David M. Epstein

2022

In 2022, David M. Epstein earned a total compensation of $1.6M as President and Chief Executive Officer at Black Diamond Therapeutics, a 68% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$310,436
Option Awards$759,775
Salary$554,350
Other$20,296
Total$1,644,857

Epstein received $759.8K in option awards, accounting for 46% of the total pay in 2022.

Epstein also received $310.4K in non-equity incentive plan, $554.4K in salary and $20.3K in other compensation.

Rankings

In 2022, David M. Epstein's compensation ranked 2,070th out of 5,753 executives tracked by ExecPay. In other words, Epstein earned more than 64.0% of executives.

ClassificationRankingPercentile
All
2,070
out of 5,753
64th
Division
Manufacturing
1,116
out of 3,133
64th
Major group
Chemicals And Allied Products
477
out of 1,419
66th
Industry group
Drugs
438
out of 1,320
67th
Industry
Biological Products, Except Diagnostic Substances
105
out of 291
64th
Source: SEC filing on April 4, 2023.

Epstein's colleagues

We found two more compensation records of executives who worked with David M. Epstein at Black Diamond Therapeutics in 2022.

2022

Brent Hatzis-Schoch

Black Diamond Therapeutics

Chief Operating Officer

2022

Fang Ni

Black Diamond Therapeutics

Chief Financial Officer

News

You may also like